Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trista K Hinz

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Seminars in Cancer Biology|September 24, 2019
Translating mesothelioma molecular genomics and dependencies into precision oncology-based therapiesTrista K Hinz, Lynn E Heasley
Molecular Pharmacology|May 25, 2021
TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor EribulinTrista K Hinz, Roshni Kalkur, Jonathan Rabinovitch, et al.
Frontiers in Oncology|February 27, 2023
Evaluation of KRAS<sup>G12C</sup> inhibitor responses in novel murine KRAS<sup>G12C</sup> lung cancer cell line modelsDaniel J Sisler, Trista K Hinz, Anh T Le, et al.
Bioinformatics (Oxford, England)|July 25, 2015
Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition dataKaren A Ryall, Jimin Shin, Minjae Yoo, et al.
Molecular Pharmacology|September 27, 2019
Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell LinesTrista K Hinz, Emily K Kleczko, Katherine R Singleton, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion OncogenesLaura Schubert, Anh T Le, Trista K Hinz, et al.
Molecular Pharmacology|February 2, 2013
A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell linesKatherine R Singleton, Jihye Kim, Trista K Hinz, et al.
Biology Open|July 20, 2023
A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenesLaura Schubert, Anh T Le, Trista K Hinz, et al.
Cancer Research|September 12, 2015
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCCKatherine R Singleton, Trista K Hinz, Emily K Kleczko, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinomaTrista K Hinz, Anh T Le, Tristan Doan, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Seminars in Cancer Biology|September 24, 2019
Translating mesothelioma molecular genomics and dependencies into precision oncology-based therapiesTrista K Hinz, Lynn E Heasley
Molecular Pharmacology|May 25, 2021
TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor EribulinTrista K Hinz, Roshni Kalkur, Jonathan Rabinovitch, et al.
Frontiers in Oncology|February 27, 2023
Evaluation of KRAS<sup>G12C</sup> inhibitor responses in novel murine KRAS<sup>G12C</sup> lung cancer cell line modelsDaniel J Sisler, Trista K Hinz, Anh T Le, et al.
Bioinformatics (Oxford, England)|July 25, 2015
Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition dataKaren A Ryall, Jimin Shin, Minjae Yoo, et al.
Molecular Pharmacology|September 27, 2019
Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell LinesTrista K Hinz, Emily K Kleczko, Katherine R Singleton, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion OncogenesLaura Schubert, Anh T Le, Trista K Hinz, et al.
Molecular Pharmacology|February 2, 2013
A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell linesKatherine R Singleton, Jihye Kim, Trista K Hinz, et al.
Biology Open|July 20, 2023
A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenesLaura Schubert, Anh T Le, Trista K Hinz, et al.
Cancer Research|September 12, 2015
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCCKatherine R Singleton, Trista K Hinz, Emily K Kleczko, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinomaTrista K Hinz, Anh T Le, Tristan Doan, et al.
Pageof 3